期刊文献+

血清MIF、MMP-9、TNF-α水平诊断冠心病合并糖尿病的临床价值 被引量:11

Clinical value of serum MIF,MMP-9 and TNF-αin the diagnosis of coronary heart disease complicated with diabetes mellitus
下载PDF
导出
摘要 目的探讨巨噬细胞移动抑制因子(MIF)、MMP-9、TNF-α水平对冠心病合并糖尿病诊断价值。方法选择本院住院患者及健康体检者共计158例作为研究对象,其中冠心病合并糖尿病患者62例为A组,单纯冠心病患者51例为B组,健康体检者45例为C组,比较3组MIF、MMP-9、TNF-α水平、A组中不同冠脉病变范围血清MIF、MMP-9、TNF-α水平以及不同Gensini积分组间血清MIF、MMP-9、TNF-α水平。结果 1 A组FBG、Hb Alc及LDL-C水平均显著高于B组、C组(P<0.05),且B组LDL-C水平显著高于C组(P<0.05);2 A组MIF、MMP-9及的表达水平显著高于B、C组(P<0.05),B组上述指标水平也均显著高于C组(P<0.05)。多支病变组指标水平均显著高于单支、双支病变组(P<0.05),双支病变组上述指标表达水平均显著高于单支病变组(P<0.05);重度组表达水平均显著高于中度、轻度组(P<0.05),中度组上述指标水平均显著高于轻度组(P<0.05)。结论冠心病合并糖尿病血清MIF、MMP-9、TNF-α水平增高,血清MIF、MMP-9、TNF-α水平对冠心病合并糖尿病具有较高的临床诊断价值。 Objective To investigate the diagnostic value of macrophage migration inhibitory factor (MIF), MMP-9 and TNF- levels in patients with coronary heart disease complicated with dia- betes mellitus. Methods A total of 158 research objects including inpatients and healthy objects were included, 62 patients with coronary heart disease complicated with diabetes mellitus were as group A, 51 patients with coronary heart disease (CHD) alone were as group B, and 45 healthy cases were as group C, MIF, MMP-9 and TNF-α levels of three groups were compared, and serum MIF, MMP-9 and TNF-αlevels of different coronary lesions in group A, the serum levels of MIF, MMP-9 and TNF-αlevel of different Gensini scores groups were compared. Results ①FBG, HbA1c and LDL-C levels in group A were significantly higher than that of group B and group C ( P 〈0. 05 ) , and LDL-C level in group B was significantly higher than that of group C ( P 〈 0.05 ) ; ②D The expression of MIF, MMP-9 and TNF-α levels in group A were significantly higher than that of B and C groups ( P 〈 0. 05 ), the above indexes in group B were significantly higher than that of group C ( P 〈 0.05 ). In addition, the levels of multi vessel disease group was significantly higher than that of single branch, and double vessel disease group (P 〈 0.05 ), expression levels in double vessel lesion group were significantly higher than that of the single vessel disease group ( P 〈 0.05 ) ; expression levels in severe group were significantly higher than those in moderate group, and mild group (P 〈 0.05 ), theabove indexes in moderate group were significantly higher than that of the mild group ( P 〈 0.05 ). Conclusion The levels of MIF, MMP-9 and TNF-α are increased in patients with coronary heart disease complicated with diabetes mellitus. The levels of serum MIF, MMP-9 and TNF-α have high clinical value in the diagnosis of coronary heart disease complicated with diabetes mellitus.
作者 刘建飞 黄鹤
出处 《实用临床医药杂志》 CAS 2016年第17期11-14,共4页 Journal of Clinical Medicine in Practice
关键词 巨噬细胞移动抑制因子 冠心病 糖尿病 macrophage migration inhibitory factor coronary heart disease diabetesmellitus
  • 相关文献

参考文献10

  • 1孙敏,刘莹莹,王晓彤,王越晖.巨噬细胞移动抑制因子与冠心病合并糖尿病的关系[J].中国实验诊断学,2014,18(3):501-503. 被引量:7
  • 2Toso C, Emamaullee J A, Eranis, et al. Theroleofmacrophage migration inhibitory factor on glucose metabolism and diabetes [J]. Diabetologia, 2008, 51 ( 11 ) : 1937 - 1946.
  • 3Sch~ttker B, Herder C, Rothenbacher D, et al. Pro-inflam- matory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or withm~t renal dysfunction: results from the ESTHER study [~ J ]. Diabetes Care, 2013, 36(6) : 1703 -1711.
  • 4Stojanovie I, Saksida T, Stosic-Grujicic S, et al. Beta cell function: the role of macrophage migration inhibitory factor [J]. Immunol Res, 2012, 52(1/2) : 81 -88.
  • 5Ferreira L, Teixeira-De-Lemos E, Pinto F, et al. Effects of sitagliptin treatment on dysmetabolism, inflammation, and ox- idative stress in an animal model of type 2 diabetes (ZDF rat) [J]. Mediators Inflamm, 2010, 2010: 592760.
  • 6Herder C, Peltonen M, Koenig W, et al. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study [ J]. Diabetologia, 2009, 52 (3) : 433 - 442.
  • 7朱遵平,余细勇,林秋雄,刘福成.血浆巨噬细胞移动抑制因子与2型糖尿病大血管病变的关系[J].岭南心血管病杂志,2009,15(1):44-46. 被引量:8
  • 8Shah Z, Kampfrath T, Deiuliis J A, et al. Long-term dipepti- dyl-peptidase 4 inhibition reduces atherosclerosis and inflam- mation via effects on monocyte recruitment and chemotaxis [ J ]. Circulation, 2011, 124 (21) : 2338 - 2349.
  • 9MUller II, Muller K A, Sch~nleber H, et al. Macrophage mi- gration inhibitory factor is enhanced in acute coronary syn- dromes and is associated with the inflammatory response [ J]. PloS One, 2012, 7(6) : e38376.
  • 10Pundziute G, Schuijf J D, Jukema J W, et al. Type 2 diabe- tes is associated with more advanced coronary atherosclerosis on muhislice computed tomography and virtual histology intra- vascular ultrasound[ J ]. J Nucl Cardiol, 2009, 16 (3) : 376 -83.

二级参考文献29

  • 1YAN S, RAMASAMY R, NAKA Y, et al. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond [J ]. Circ Res, 2003, 93 (10): 1159-1169.
  • 2YABUNAKA N, NISHIHIRA J, MIZUE Y, et al. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes[J]. Diabetes Care, 2002, 23(2) : 256-258.
  • 3AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes-2008 [J]. Diabetes Care, 2008, 31 (suppl 1) : s12-s54.
  • 4RIDKER P M, RIFAI N, ROSE L, et al. Comparison of C- reactive protein and low-density lipopmtein cholesterol levels in the prediction of first cadiovascular events [J ]. N Eng J Med, 2002, 347 (20): 1557-1564.
  • 5HERDER C, KOBL H, KOENIG W, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the finnish diabetes prevention study [ J ]. Diabetes, 2006, 55 (8): 2340-2346.
  • 6HERDER C, KOLB H, KOENIG W, et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4) [J]. Diabetes Care, 2006, 29 (2): 368-371.
  • 7HERDER C, KLOPP N, BAUMERT J, et al. Effect of macrophage migration inhibitory factor (MlF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002[J]. Diabetologia, 2008, 51 (2): 276-284.
  • 8Francis K, Lewis BM, Monk PN, et al. Complement CSa receptors in the pituitary gland: expression and function[J]. J Endocrinol, 2008,199(3) :417.
  • 9Morand EF, Leech M, Bernhagen J. MIF:a new cytokine link be tween rheumatoid arthritis and atherosclerosls[J]. Nature Re views Drug Discov, 2005,5 : 399.
  • 10Leng L,Metz CN,Fang Y,et al. MIF signal transduction initiated by binding to CD74[J]. J Exp Med,2003,197(11):1467.

共引文献12

同被引文献99

引证文献11

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部